Data as of May 22
| +0.1675 / +6.98%|
The 1 analysts offering 12-month price forecasts for Prima BioMed Ltd have a median target of 0.01, with a high estimate of 0.01 and a low estimate of 0.01. The median estimate represents a -99.69% decrease from the last price of 2.57.
The current consensus among 2 polled investment analysts is to Buy stock in Prima BioMed Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.